Advertisement

Anticipating Diabetes, Obesity and Polycystic Ovarian Syndrome and Applying Integrative Techniques Using Functional and Oriental Medicine

  • Dagmar EhlingEmail author
Chapter
  • 526 Downloads

Abstract

Metabolic syndrome is rampant in our society with increases of epidemic proportions in obesity and diabetes. This paper provides an overview of integrative medical diagnostic and treatment options that favor proactive interventions to prevent the long-term consequences of these maladies. Topics include Oriental medicine, blood sugar balance, adrenal health, immune system, hormones, brain health, dietary modifications, including their application for patients with polycystic ovarian syndrome (PCOS), a major cause of infertility. This approach offers useful and safe alternatives to drug therapy, bariatric surgery, and in the case of PCOS, assisted reproductive technologies, which have known risks, complications, and high costs. This paper suggests new possibilities for managing these issues proactively and effectively. Anticipation of outcomes of dysfunctional lifestyle choices offers the opportunity to prevent disease, i.e., “treat” it, before it occurs.

Keywords

Diabetes Obesity Acupuncture Functional medicine Polycystic ovarian disease Oriental medicine Paleolithic diet 

References

  1. 1.
    Centers for Disease Control and Prevention. Defining Overweight and Obesity. http://www.cdc.gov/obesity/adult/defining.html
  2. 2.
    American Diabetes Association. Diagnosing Diabetes and Learning About Prediabetes. http://www.diabetes.org/diabetes-basics/diagnosis/
  3. 3.
    Centers for Disease Control and Prevention. PowerPoint Slides on Diabetes. http://www.cdc.gov/diabetes/data/center/slides.html
  4. 4.
    Centers for Disease Control and Prevention. Press Release October 22, 2010. http://www.cdc.gov/media/pressrel/2010/r101022.html
  5. 5.
    Shaw, J.E., Sicree, R.A., Zimmet, P.Z.: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4–14 (2010)CrossRefGoogle Scholar
  6. 6.
    Medline Plus. Type 2 Diabetes: Causes, Symptoms, Exams and Tests, Treatment. http://www.nlm.nih.gov/medlineplus/ency/article/000313.htm
  7. 7.
    Finkelstein, E.A., Khavjou, O.A., Thompson, H., Trogdon, J.G., Pan, L., Sherry, B., Dietz, W.: Obesity and severe obesity forecasts through 2030. Am. J. Prev. Med. 42(6), 563–570 (2012)CrossRefGoogle Scholar
  8. 8.
    United States Department of Agriculture. Agriculture factbook 2001–2002: profiling food consumption in America. (2002). http://www.diet.com/g/usda-food-guide-pyramid-mypyramid
  9. 9.
    United States Department of Agriculture. Nutrition and Your Health: Dietary Guidelines for Americans, Appedix G-5: History of the Dietary Guidelines for Americans. http://www.health.gov/dietaryguidelines/dga2005/report/html/G5_History.htm
  10. 10.
    Ogden, C.L., Carroll, M.D.: Division of Health and Nutrition Examination Surveys; Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960–1962 Through 2007–2008. www.cdc.gov/NCHS/data/hestat/obesity_adult_07_08/obesity_adult_07_08.pdf
  11. 11.
    Zhou, S.S., Li, D., Zhou, Y.M., Sun, W.P., Liu, Q.G.: B-vitamin consumption and the prevalence of diabetes and obesity among the US adults: population based ecological study. BMC Public Health 10, 746 (2010). http://openi.nlm.nih.gov/detailedresult.php?img=3014900_1471–2458-10-746-8&req=4
  12. 12.
    United States Department of Agriculture. A Brief History of USDA Food Guides. Center for Nutrition Policy and Promotion, June 2011. http://fnic.nal.usda.gov/dietary-guidance/myplate-and-historical-food-pyramid-resources/past-food-pyramid-materials
  13. 13.
    United States Department of Agriculture. Center for Nutrition Policy and Promotion. MyPlate (2010). http://www.cnpp.usda.gov/MyPlate
  14. 14.
    American Diabetes Association. The Cost of Diabetes. http://www.diabetes.org/advocacy/news-events/cost-of-diabetes.html
  15. 15.
    Witters, D., Harter, J., Bell, K., Ray, J.: The cost of obesity to US cities, gallup business journal, gallup-healthways well-being index. http://businessjournal.gallup.com/content/145778/cost-obesity-cities.aspx#1
  16. 16.
    Cawley, J., Rizzo, J.A., Haas, K.: Occupation-specific absenteeism costs associated with obesity and morbid obesity. J. Occup. Environ. Med. 49(12), 1317–1324 (2007)CrossRefGoogle Scholar
  17. 17.
    Ehling, D.: Integrative techniques using acupuncture, Chinese herbal medicine, diet, and supplements for polycystic ovary syndrome: a case report. J. Integr. Med. 11(6), 422–427 (2013)CrossRefGoogle Scholar
  18. 18.
    Centers for Disease Control and Prevention. Diabetes Public Health Resource. Diabetes Complications. http://www.cdc.gov/diabetes/statistics/complications_national.htm
  19. 19.
    De la Monte, S., Wands, J.R.: Alzheimer’s disease is type 3 diabetes—evidence reviewed. J. Diabetes Sci Technol. 2(6), 1101–1113 (2008)CrossRefGoogle Scholar
  20. 20.
    Emerging Risk Factors Collaboration. Seshasai, S.R., Kaptoge, S., Thompson, A., Di Angelantonio, E., Gao, P., Sarwar, N., Whincup, P.H., Mukamal, K.J., Gillum, R.F., Holme, I., Njølstad, I., Fletcher, A., Nilsson, P., Lewington, S., Collins, R., Gudnason, V., Thompson, S.G., Sattar, N., Selvin, E., Hu, F.B., Danesh, J.: Diabetes mellitus, fasting glucose, and the risk of cause-specific death. N. Engl. J. Med. 364, 829–841 (2011)Google Scholar
  21. 21.
    Lee, J.S., Cho, S.I., Park, H.S.: Metabolic Syndrome and cancer-related mortality among Korean men and women. Ann. Oncol. 21(3), 640–645 (2010)CrossRefGoogle Scholar
  22. 22.
    Goodwin, P.J., Ennis, M., Pritchard, K.I., Trudeau, M.E., Koo, J., Madamas, Y., Hartwick, W., Hoffman, B., Hood, N.: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J. Clin. Oncol. 20(1), 42–51 (2002)Google Scholar
  23. 23.
    Centers for Disease Control and Prevention. Vital Signs, Medical Complications of Obesity. http://www.cdc.gov/vitalsigns/AdultObesity/Risk-large.html
  24. 24.
    American Diabetes Association. Diabetes Symptoms. http://www.diabetes.org/diabetes-basics/symptoms/
  25. 25.
    Kharrazian, D.: Metabolic Assessment Form 2012Google Scholar
  26. 26.
    De la Monte, S., Wands, J.R.: Alzheimer’s disease is type 3 diabetes—evidence reviewed. J. Diabetes Sci. Technol. 2(6), 1101–1113 (2008)CrossRefGoogle Scholar
  27. 27.
    Enzinger, C., Fazekas, F., Matthews, P.M., Ropele, S., Schmidt, H., Smith, S., Schmidt, R.: Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 64(10), 1704–1711 (2005)CrossRefGoogle Scholar
  28. 28.
    den Heijer, T., Vermeer, S.E., van Dijk, E.J., Prins, N.D., Koudstaal, P.J., Hofman, A., Breteler, M.M.: Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46(12), 1604–1610 (2003)CrossRefGoogle Scholar
  29. 29.
    McAuley, M.T., Kenny, R.A., Kirkwood, T.B., Wilkinson, D.J., Jones, J.J., Miller, V.M.: A mathematical model of aging-related and cortisol induced hippocampal dysfunction. BMC Neurosci. 25(10), 26 (2009). doi: 10.1186/1471-2202-10-26 CrossRefGoogle Scholar
  30. 30.
    Frey, D.J., Fleshner, M., Wright Jr., K.P.: The effects of 40 hours of total sleep deprivation on inflammatory markers in healthy young adults. Brain Behav. Immun. 21(8), 1050–1057 (2007). Epub 2007 May 23CrossRefGoogle Scholar
  31. 31.
    Gill, J., Vythilingam, M., Page, G.G.: Low cortisol, high DHEA, and high levels of stimulated TNFα, and IL-6 in women with PTSD. J. Trauma. Stress 21(6), 530–539 (2008). doi: 10.1002/jts.20372 CrossRefGoogle Scholar
  32. 32.
    Yan, Z., Banerjee, R.: Redox remodeling as an immunoregulatory strategy. Biochemistry 49(6), 1059–1066 (2010). doi: 10.1021/bi902022n CrossRefGoogle Scholar
  33. 33.
    Fraternale, A., Paoletti, M.F., Casabianca, A., Oiry, J., Clayette, P., Vogel, J.U., Cinatl Jr., J., Palamara, A.T., Sgarbanti, R., Garaci, E., Millo, E., Benatti, U., Magnani, M.: Antiviral and immunomodulatory properties of new pro-glutathione (GSH) molecules. Curr. Med. Chem. 13(15), 1749–1755 (2006)CrossRefGoogle Scholar
  34. 34.
    Lucas, R.M., Gorman, S., Geldenhuys, S., Hart, P.H.: Vitamin D and immunity. F1000Prime Rep. 1;6, 118. doi:10.12703/P6-118 (2014). eCollection 2014Google Scholar
  35. 35.
    Gareau, M.G., Silva, M.A., Perdue, M.H.: Pathophysiological mechanisms of stress-induced intestinal damage. Curr. Mol. Med. 8(4), 274–281 (2008)CrossRefGoogle Scholar
  36. 36.
    Alonso, C., Guilarte, M., Vicario, M., Ramos, L., Ramadan, Z., Antolín, M., Martínez, C., Rezzi, S., Saperas, E., Kochhar, S., Santos, J., Malagelada, J.R.: Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation. Gastroenterology. 135(1), 163–172.e1 (2008). doi: 10.1053/j.gastro.2008.03.036. Epub 2008 Mar 22
  37. 37.
    Bansal, V., Costantini, T., Kroll, L., Peterson, C., Loomis, W., Eliceiri, B., Baird, A., Wolf, P., Coimbra, R.: Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis. J. Neurotrauma 26(8), 1353–1359 (2009). doi: 10.1089/neu.2008-0858 CrossRefGoogle Scholar
  38. 38.
    Koyuncu, A., Aydintu, S., Koçak, S., Aydin, C., Demirer, S., Topçu, O., Kuterdem, E.: Effect of thyroid hormones on stress ulcer formation. ANZ J. Surg. 72(9), 672–675 (2002)CrossRefGoogle Scholar
  39. 39.
    Visser, J., Rozing, J., Sapone, A., Lammers, K., Fasano, A.: Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann. N. Y. Acad. Sci. 1165, 195–205 (2009). doi: 10.1111/j.1749-6632.2009.04037.x CrossRefGoogle Scholar
  40. 40.
    Li, Y.C., Chen, Y., Du, J.: Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation. J. Steroid Biochem. Mol. Biol. 17. pii: S0960–0760(15)00013-8 (2015). doi: 10.1016/j.jsbmb.2015.01.011
  41. 41.
    Tang, Y., et al.: Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol. Clin. Exp. Res. 33(7), 1220–1230 (2009). (Epub 2009 Apr 9)CrossRefGoogle Scholar
  42. 42.
    Spritzer, P.M., Lecke, S.B., Satler, F., Morsch, D.M.: Adipose tissue dysfunction, adipokines and low-grade chronic inflammation in PCOS. Reproduction. (2015) pii: REP-14-0435Google Scholar
  43. 43.
    Zitzmann, M.: Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat. Rev. Endocrinol. 5(12), 673–681 (2009). doi: 10.1038/nrendo.2009.212. (Epub 2009 Oct 27)CrossRefGoogle Scholar
  44. 44.
    Dandona, P., Dhindsa, S., Chaudhuri, A., Bhatia, V., Topiwala, S.: Hypogonadotrophic hypogonadism in type 2 diabetes. Aging Male. 11(3), 107–117 (2008). doi: 10.1080/13685530802317934 CrossRefGoogle Scholar
  45. 45.
    Ramezani-Binabaj, M., Motalebi, M., Karimi-Sari, H., Rezaee-Zavareh, M.S., Alavian, S.M.: Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis. Hepat Mon. 14(11):e23235 (2014). doi: 10.5812/hepatmon.23235 (eCollection 2014)
  46. 46.
    Vassilatou, E.: Nonalcoholic fatty liver disease and polycystic ovary syndrome. World J. Gastroenterol. 20(26), 8351–8363 (2014). doi: 10.3748/wjg.v20.i26.8351 CrossRefGoogle Scholar
  47. 47.
    Gaberšček, S., Zaletel, K., Schwetz, V., Pieber, T., Obermayer-Pietsch, B., Lerchbaum, E.: Mechanisms in endocrinology: thyroid and polycystic ovary syndrome. Eur. J. Endocrinol. 172(1), R9–R21 (2015). doi: 10.1530/EJE-14-0295 CrossRefGoogle Scholar
  48. 48.
    Janssen, O.E., et al.: High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur. J. Endocrinol. 150(3), 363–369 (2004)CrossRefGoogle Scholar
  49. 49.
    Garelli, S. et al.: High Prevalence in chronic thyroiditis in patients with polycystic ovarian syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. (2013). pii: S0301-2115(13)00116-4 (Epup ahead of print)Google Scholar
  50. 50.
    Gonzales, F., et al.: Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism 48(4), 437–441 (1999)CrossRefGoogle Scholar
  51. 51.
    Fukui, M., Tanaka, M., Toda, H., Okada, H., Ohnishi, M., Mogami, S., Kitagawa, Y., Hasegawa, G., Yoshikawa, T., Nakamura, N.: Andropausal symptoms in men with Type 2 diabetes. Diabet. Med. 29(8), 1036–1042 (2012). doi: 10.1111/j.1464-5491.2012.03576.x
  52. 52.
    Pal, S.K.: Complementary and alternative medicine: an overview. Current Sci. 82(5), 518–524 (2002)Google Scholar
  53. 53.
    Nadin, M.: Medicine: the decisive test of anticipation. In: Nadin, M. (ed.) Anticipation and Medicine, pp. 1–25. Springer, Cham (2016)Google Scholar
  54. 54.
    Gatherer, D.: So what do we really mean when we say that systems biology is holistic? BMC Syst. Biol. 4, 22 (2010) doi: 10.1186/1752-0509-4-22. http://bmcsystbiol.biomedcentral.com/articles/10.1186/1752–0509-4-22
  55. 55.
    Wang, M., Lamers, R.J., Korthout, H.A., van Nesselrooij, J.H., Witkamp, R.F., Heijden, R. van der, Voshol, P.J., Havekes, L.M., Verpoorte. R., Greef, J. van der.: Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother Res. 19, 173–182 (2005). doi: 10.1002/ptr.162
  56. 56.
    Ehling, D.: Oriental medicine: an introduction. Altern. Ther. Health Med. 7(4), 71-82 (2001)Google Scholar
  57. 57.
    University of California San Francisco Medical Center. Acupuncture. http://www.ucsfhealth.org/treatments/acupuncture/
  58. 58.
    Vickers, A., Zollman, C.: Acupuncture. BMJ 319(7215), 873–976 (1999)CrossRefGoogle Scholar
  59. 59.
    Joswick, D.: What are the different styles of acupuncture? Acufinder.com https://www.acufinder.com/Acupuncture+Information/Detail/What+are+the+different+styles+of+acupuncture+
  60. 60.
    Five Element Linking Fist. https://theory.yinyanghouse.com/theory/chinese/five_element_acupuncture_theory. [See also http://www.axelradclinic.com/]. Five Element associations adapted and modified from Chris Axelrad LAc. Lecture notes Integrative Fertility Symposium. 2015. Vancouver, Canada. Please note that OM terms are capitalized to distinguish them from Western meanings. For example, kidneys, two anatomical organs located within the posterior thoracic cavity, is different from Kidney, and Organ that, among other things, rules the bones, teeth and marrow.
  61. 61.
    Hyman, M.: The Blood Sugar Solution. Little, Brown and Company (2012)Google Scholar
  62. 62.
    Cleveland Clinic. Center for Functional Medicine. http://my.clevelandclinic.org/services/center-for-functional-medicine
  63. 63.
    Westman, E.: A Low Carbohydrate, Ketogenic Diet Manual. No Sugar, No Starch Diet. 2013. CreateSpace Independent Publishing PlatformGoogle Scholar
  64. 64.
    Let’s take back your health. http://chriskresser.com/
  65. 65.
    Sanfilippo, D.: Practical Paleo. 30-Day Meal Plans. 2012. Victory Belt Publishing, Inc. http://balancedbites.com/practicalpaleo
  66. 66.
  67. 67.
    Dr. Sarah Ballantyne and the Paleo Diet. http://www.thepaleomom.com
  68. 68.
    Ballantyne, S.: The Paleo Approach Cookbook: A Detailed Guide to Heal Your Body and Nourish Your Soul. 2014. Victory Belt Publishing, Inc. http://www.thepaleomom.com/about-the-paleo-mom/the-paleo-approach-cookbook
  69. 69.
    Boers, I., Muskiet, F.A., Berkelaar, E., Schut, E., Penders, R., Hoenderdos, K., Wichers, H.J., Jong, M.C.: Favourable effects of consuming a Palaeolithic-type diet on characteristics of the metabolic syndrome: a randomized controlled pilot-study. Lipids Health Dis. 11(13), 160 (2014). doi: 10.1186/1476-511X-13-160 CrossRefGoogle Scholar
  70. 70.
    Stomby, A., Simonyte, K., Mellberg, C., Ryberg, M., Stimson, R.H., Larsson, C., Lindahl, B., Andrew, R., Walker, B.R., Olsson, T.: Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women. Int. J. Obes. (Lond). (2014). doi: 10.1038/ijo.2014.188 Google Scholar
  71. 71.
    Masharani, U., Sherchan, P., Schloetter, M., Stratford, S., Xiao, A., Sebastian, A., Nolte Kennedy, M., Frassetto, L.: Metabolic and physiologic effects from consuming a hunter-gatherer (Paleolithic)-type diet in type 2 diabetes. Eur. J. Clin. Nutr. doi: 10.1038/ejcn.2015.39 (2015). http://www.ncbi.nlm.nih.gov/pubmed/25828624
  72. 72.
    Yancy, Jr, W.S., Foy, M., Chalecki, A.M., Vernon, M.C., Westman, E.C.: A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr. Metab. 2, 34 (2005). doi: 10.1186/1743-7075-2-34
  73. 73.
    Westman, E.C., Yancy Jr., W.S., Mavropoulos, J.C., Marquart, M., McDuffie, J.R.: The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet glycemic control in type 2 diabetes mellitus. Nutr. Metab. (Lond). 18(5), 36 (2008). doi: 10.1186/1743-7075-5-36 CrossRefGoogle Scholar
  74. 74.
    Gower, B.A., Goss, A.M.: A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J. Nutr. 145(1), 177S–183S (2015). doi: 10.3945/jn.114.195065. (Epub 2014 Dec 3)CrossRefGoogle Scholar
  75. 75.
    Goss, A.M., Chandler-Laney, P.C., Ovalle, F., Goree, L.L., Azziz, R., Desmond, R.A., Wright Bates, G., Gower, B.A.: Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism. 63(10), 1257–1264 (2014). doi: 10.1016/j.metabol.2014.07.007 (Epub 2014 July 18)
  76. 76.
    Suez, J., Korem, T., Zeevi, D., et al.: Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514(7521), 181–186 (2014)Google Scholar
  77. 77.
  78. 78.
  79. 79.
    Matsumoto, K., Euler, D.: Kiiko Matsumot’s clinical strategies vols. 1 and 2. 2004 and 2008, Kiiko Matsumoto International, Natick, MAGoogle Scholar
  80. 80.
    Maciocia, G.: The Foundations of Chinese Medicine. Churchill Livingstone Inc. (1989)Google Scholar
  81. 81.
    Bensky, D., Barolet, R.L.: Chinese Herbal Medicine—Formula & Strategies. Eastland Press Inc. (1990)Google Scholar
  82. 82.
    Huang, H.: Ten Key Formula Families in Chinese Medicine. Trans. Max M. Eastland Press Inc. (2009)Google Scholar
  83. 83.
    Ehling, D., Swart, S.: The Chinese Herbalist’s Handbook, 2nd edn. In Word Press (1996)Google Scholar
  84. 84.
    Marcinko, K., Sikkema, S.R., Smaan, M.C., Kemp, B.E., Fullerton, M.D., Steinberg, G.R.: High Intensity interval training improves liver and adipose tissue insulin sensitivity. Mol. Metb. 4(12), 903–915 (2015). doi: 10.1016/j.molmet.2015.09.006. eCollection 2015. http://www.ncbi.nlm.nih.gov/pubmed/26909307
  85. 85.
    Lemes, I.R., Ferreira, P.H., Linares, S.N., Machado, A.F., Pastr, Cm, N.J. Jr.: Resistance training reduces systolic blood pressure in metabolic syndrome: a systematic review and meta-analysis of randomised controlled trials. Br. J. Sports Med. Pii: bjsports-2015-094715. doi: 10.1136/bjsports-2015-094715. [Epub ahead of print] http://www.ncbi.nlm.nih.gov/pubmed/26964146
  86. 86.
    International Conference: Anticipation and Medicine, Hanse Wissenschaftskolleg, Delmenhorst, Germany, September 28–30 (2015)Google Scholar
  87. 87.
    Nadin, M. (ed.): Anticipation across disciplines. cognitive systems monographs, vol. 29. Springer, Cham CH (2015) http://www.springer.com/us/book/9783319225982
  88. 88.
    The European Association for Predictive, Preventative & Personalized Medicine. http://www.epmanet.eu

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Oriental Health Solutions, LLCDurhamUSA
  2. 2.Forschungsgruppe AkupunkturDüsseldorf und GrafingGermany

Personalised recommendations